Phase III trial comparing paclitaxel poliglumex (CT-2103, PPX) in combination with carboplatin versus standard paclitaxel and carboplatin in the treatment of PS 2 patients with chemotherapy-naïve advanced non-small cell lung cancer

Corey J. Langer, Kenneth J. O'Byrne, Mark A. Socinski, Sergei M. Mikhailov, Krzysztof Leśniewski-Kmak, Martin Smakal, Tudor E. Ciuleanu, Sergey V. Orlov, Mircea Dediu, David Heigener, Amy J. Eisenfeld, Larissa Sandalic, Fred B. Oldham, Jack W. Singer, Helen J. Ross

Research output: Contribution to journal › Article › peer-review

154 Scopus citations

Fingerprint

Dive into the research topics of 'Phase III trial comparing paclitaxel poliglumex (CT-2103, PPX) in combination with carboplatin versus standard paclitaxel and carboplatin in the treatment of PS 2 patients with chemotherapy-naïve advanced non-small cell lung cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences